Income Statement Agilent Technologies, Inc.

Equities

A

US00846U1016

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2026-02-10 pm EST			5-day change	1st Jan Change
129.00 ^USD	+1.18%		-2.38%	-5.20%

Feb. 10	FDA approves pembrolizumab with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, primary peritoneal carcinoma	RE
Feb. 04	Agilent Technologies Inc. Showcases Next-Generation Automated Solutions at SLAS2026	CI

3aa1c631cf17302d1b54eb1.dgeelPYnukQ93RW-LO1wkPE7VuDcxm3XpoQEyFCpaYw.QVjN_bV39RwLjkLYToMv3bMDAaLkrDfkxNxOigffM8YGcfv2rFCXI3GvRA

Published financial data: AGILENT TECHNOLOGIES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: October	2021	2022	2023	2024	2025
Revenues	6.32B	6.85B	6.83B	6.51B	6.95B
Total Revenues	6.32B	6.85B	6.83B	6.51B	6.95B
Cost of Goods Sold, Total	2.91B	3.13B	3.37B	2.98B	3.3B
Gross Profit	3.41B	3.72B	3.46B	3.54B	3.64B
Selling General & Admin Expenses, Total	1.56B	1.58B	1.58B	1.48B	1.52B
R&D Expenses	441M	467M	481M	452M	450M
Other Operating Expenses, Total	2B	2.04B	2.06B	1.93B	1.98B
Operating Income	1.4B	1.68B	1.41B	1.61B	1.67B
Interest Expense, Total	-81M	-84M	-95M	-96M	-112M
Interest And Investment Income	2M	9M	51M	80M	62M
Net Interest Expenses	-79M	-75M	-44M	-16M	-50M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-4M	-6M	-2M	-4M	-3M
Other Non Operating Income (Expenses)	15M	14M	62M	20M	20M
EBT, Excl. Unusual Items	1.34B	1.61B	1.42B	1.61B	1.64B
Restructuring Charges	-37M	-30M	-25M	-74M	-130M
Merger & Related Restructuring Charges	-41M	-25M	-16M	-12M	-19M
Gain (Loss) On Sale Of Investments	98M	-67M	-41M	6M	-51M
Asset Writedown	-	-	-	-	-
In Process R&D Expenses	-	-	-	-6M	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	4M	16M	-1M	-	-
EBT, Incl. Unusual Items	1.36B	1.5B	1.34B	1.52B	1.44B
Income Tax Expense	150M	250M	99M	232M	132M
Earnings From Continuing Operations	1.21B	1.25B	1.24B	1.29B	1.3B
Net Income to Company	1.21B	1.25B	1.24B	1.29B	1.3B
Net Income - (IS)	1.21B	1.25B	1.24B	1.29B	1.3B
Net Income to Common Incl Extra Items	1.21B	1.25B	1.24B	1.29B	1.3B
Net Income to Common Excl. Extra Items	1.21B	1.25B	1.24B	1.29B	1.3B
Per Share Items
Net EPS - Basic	3.98	4.19	4.22	4.44	4.59
Basic EPS - Continuing Operations	3.98	4.19	4.22	4.44	4.59
Basic Weighted Average Shares Outstanding	304M	299M	294M	290M	284M
Net EPS - Diluted	3.94	4.18	4.19	4.43	4.57
Diluted EPS - Continuing Operations	3.94	4.18	4.19	4.43	4.57
Diluted Weighted Average Shares Outstanding	307M	300M	296M	291M	285M
Normalized Basic EPS	2.75	3.37	3.02	3.46	3.6
Normalized Diluted EPS	2.72	3.35	3	3.45	3.59
Dividend Per Share	0.78	0.84	0.9	0.94	0.99
Payout Ratio	19.5	19.94	21.37	21.26	21.64
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	1.72B	1.99B	1.68B	1.86B	1.96B
EBITA	1.6B	1.87B	1.55B	1.71B	1.77B
EBIT	1.4B	1.68B	1.41B	1.61B	1.67B
EBITDAR	1.79B	2.06B	1.75B	1.92B	2.01B
Total Revenues (As Reported)	6.32B	6.85B	6.83B	6.51B	6.95B
Effective Tax Rate - (Ratio)	11.03	16.62	7.39	15.25	9.2
Current Domestic Taxes	139M	195M	129M	209M	114M
Current Foreign Taxes	-3M	47M	26M	87M	148M
Total Current Taxes	136M	242M	155M	296M	262M
Deferred Domestic Taxes	0	-27M	-94M	-124M	-114M
Deferred Foreign Taxes	14M	35M	38M	60M	-16M
Total Deferred Taxes	14M	8M	-56M	-64M	-130M
Normalized Net Income	835M	1.01B	889M	1B	1.02B
Interest on Long-Term Debt	81M	84M	-	-	-
Non-Cash Pension Expense	2M	-18M	-8M	-23M	-36M
Supplemental Operating Expense Items
Advertising Expense	63M	66M	54M	49M	50M
Selling and Marketing Expenses	-	-	-	49M	50M
Research And Development Expense From Footnotes	441M	467M	481M	479M	455M
Net Rental Expense, Total	62M	62M	70M	56M	51M
Imputed Operating Lease Interest Expense	14.75M	14.29M	18.28M	13.29M	12.84M
Imputed Operating Lease Depreciation	47.25M	47.71M	51.72M	42.71M	38.16M
Stock-Based Comp., COGS (Total)	26M	30M	34M	41M	44M
Stock-Based Comp., R&D Exp. (Total)	12M	14M	13M	16M	15M
Stock-Based Comp., SG&A Exp. (Total)	73M	82M	65M	73M	70M
Total Stock-Based Compensation	111M	126M	112M	130M	129M

Fiscal Period: October	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.48B	1.05B	1.59B	1.33B	1.79B
Short Term Investments	91M	-	-	-	-
Total Cash And Short Term Investments	1.58B	1.05B	1.59B	1.33B	1.79B
Accounts Receivable, Total	1.17B	1.4B	1.29B	1.32B	1.49B
Other Receivables	66M	87M	100M	147M	108M
Total Receivables	1.24B	1.49B	1.39B	1.47B	1.6B
Inventory	830M	1.04B	1.03B	972M	1.02B
Other Current Assets, Total	156M	195M	174M	187M	185M
Total Current Assets	3.8B	3.78B	4.19B	3.96B	4.59B
Gross Property Plant And Equipment	2.24B	2.4B	2.65B	3.26B	3.63B
Accumulated Depreciation	-1.12B	-1.15B	-1.22B	-1.3B	-1.42B
Net Property Plant And Equipment	1.12B	1.25B	1.42B	1.96B	2.21B
Long-term Investments	185M	195M	164M	175M	133M
Goodwill	3.98B	3.95B	3.96B	4.48B	4.47B
Other Intangibles, Total	981M	821M	475M	547M	445M
Deferred Tax Assets Long-Term	309M	246M	284M	351M	427M
Other Long-Term Assets, Total	333M	290M	270M	382M	449M
Total Assets	10.7B	10.53B	10.76B	11.85B	12.73B
Liabilities
Accounts Payable, Total	446M	580M	418M	540M	570M
Accrued Expenses, Total	626M	580M	529M	530M	606M
Short-term Borrowings	-	36M	-	45M	300M
Current Portion of Long-Term Debt	-	-	-	-	4M
Current Portion of Leases	52M	52M	46M	42M	44M
Current Income Taxes Payable	47M	51M	73M	152M	143M
Unearned Revenue Current, Total	441M	461M	505M	544M	624M
Other Current Liabilities	96M	101M	32M	42M	56M
Total Current Liabilities	1.71B	1.86B	1.6B	1.9B	2.35B
Long-Term Debt	2.73B	2.73B	2.74B	3.34B	3.05B
Long-Term Leases	130M	101M	118M	142M	145M
Unearned Revenue Non Current	78M	96M	111M	157M	179M
Pension & Other Post Retirement Benefits	220M	97M	103M	130M	126M
Deferred Tax Liability Non Current	103M	58M	38M	85M	47M
Other Non Current Liabilities	348M	281M	210M	194M	92M
Total Liabilities	5.32B	5.23B	4.92B	5.95B	5.99B
Common Stock, Total	3M	3M	3M	3M	3M
Additional Paid In Capital	5.32B	5.32B	5.39B	5.45B	5.58B
Retained Earnings	348M	324M	782M	750M	1.39B
Treasury Stock	-	-	-	-	-
Comprehensive Income and Other	-282M	-347M	-327M	-305M	-226M
Total Common Equity	5.39B	5.3B	5.84B	5.9B	6.74B
Minority Interest	-	-	-	-	-
Total Equity	5.39B	5.3B	5.84B	5.9B	6.74B
Total Liabilities And Equity	10.7B	10.53B	10.76B	11.85B	12.73B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	302M	296M	293M	286M	283M
ECS Total Common Shares Outstanding	302M	295M	292M	285M	283M
Book Value / Share	17.83	17.97	20.01	20.68	23.82
Tangible Book Value	433M	532M	1.41B	874M	1.82B
Tangible Book Value Per Share	1.43	1.8	4.83	3.06	6.44
Total Debt	2.91B	2.92B	2.9B	3.57B	3.54B
Net Debt	1.34B	1.87B	1.31B	2.24B	1.75B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-32M	-122M	-125M	-193M	-264M
Debt Equivalent Oper. Leases	496M	496M	560M	448M	408M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	367M	483M	461M	449M	478M
Inventories - Finished Goods, Total	463M	555M	570M	523M	547M
Land - (BS)	61M	59M	60M	69M	69M
Buildings, Total	1.15B	1.26B	1.41B	1.79B	2.06B
Machinery, Total	638M	674M	749M	960M	1.04B
Full Time Employees	17K	18.1K	18.1K	17.9K	18.1K

Fiscal Period: October	2021	2022	2023	2024	2025
Net Income	1.21B	1.25B	1.24B	1.29B	1.3B
Depreciation & Amortization - CF	126M	125M	131M	152M	183M
Amortization of Goodwill and Intangible Assets - (CF)	195M	192M	140M	105M	105M
Depreciation & Amortization, Total	321M	317M	271M	257M	288M
(Gain) Loss From Sale Of Asset	-	-	-43M	-	-
(Gain) Loss on Sale of Investments - (CF)	-98M	67M	41M	-6M	36M
Asset Writedown & Restructuring Costs	2M	-	277M	19M	15M
Stock-Based Compensation (CF)	110M	125M	111M	129M	128M
Other Operating Activities, Total	42M	27M	-9M	-20M	-80M
Change In Accounts Receivable	-128M	-321M	132M	7M	-149M
Change In Inventories	-136M	-248M	-33M	34M	-97M
Change In Accounts Payable	64M	121M	-171M	103M	16M
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	98M	-30M	-44M	-61M	99M
Cash from Operations	1.48B	1.31B	1.77B	1.75B	1.56B
Capital Expenditure	-188M	-291M	-298M	-378M	-407M
Sale of Property, Plant, and Equipment	1M	-	-	-	-
Cash Acquisitions	-546M	-52M	-51M	-862M	4M
Divestitures	-	-	50M	-	-
Sale (Purchase) of Intangible assets	-1M	-	-	-	-
Investment in Marketable and Equity Securities, Total	-10M	9M	-3M	-5M	8M
Other Investing Activities, Total	-5M	-4M	-8M	-13M	1M
Cash from Investing	-749M	-338M	-310M	-1.26B	-394M
Short Term Debt Issued, Total	1.65B	1.3B	-	40M	-
Long-Term Debt Issued, Total	848M	600M	-	1.2B	4M
Total Debt Issued	2.5B	1.9B	-	1.24B	4M
Short Term Debt Repaid, Total	-1.72B	-1.26B	-35M	-	-42M
Long-Term Debt Repaid, Total	-417M	-609M	-	-600M	-3M
Total Debt Repaid	-2.14B	-1.87B	-35M	-600M	-45M
Issuance of Common Stock	55M	58M	67M	77M	72M
Repurchase of Common Stock	-864M	-1.21B	-629M	-1.18B	-464M
Common Dividends Paid	-236M	-250M	-265M	-274M	-282M
Common & Preferred Stock Dividends Paid	-236M	-250M	-265M	-274M	-282M
Other Financing Activities, Total	-7M	-	-68M	-9M	-
Cash from Financing	-696M	-1.37B	-930M	-752M	-715M
Foreign Exchange Rate Adjustments	3M	-36M	5M	-2M	9M
Net Change in Cash	43M	-434M	537M	-261M	459M
Supplemental Items
Cash Interest Paid	76M	85M	89M	80M	101M
Cash Income Tax Paid (Refund)	211M	279M	199M	314M	318M
Levered Free Cash Flow	1.13B	764M	816M	1.17B	998M
Unlevered Free Cash Flow	1.19B	816M	876M	1.23B	1.07B
Change In Net Working Capital	-65M	384M	88M	-217M	-16M
Net Debt Issued / Repaid	356M	26M	-35M	637M	-41M

Fiscal Period: October	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.63	9.87	8.25	8.88	8.48
Return on Total Capital	11.17	12.68	10.36	11.03	10.55
Return On Equity %	23.58	23.45	22.24	21.95	20.62
Return on Common Equity	23.58	23.45	22.24	21.95	20.62
Margin Analysis
Gross Profit Margin %	53.92	54.35	50.71	54.3	52.43
SG&A Margin	24.72	23.04	23.09	22.67	21.95
EBITDA Margin %	27.3	29.12	24.54	28.63	28.15
EBITA Margin %	25.3	27.29	22.63	26.3	25.52
EBIT Margin %	22.22	24.49	20.58	24.68	24.01
Income From Continuing Operations Margin %	19.15	18.31	18.15	19.8	18.75
Net Income Margin %	19.15	18.31	18.15	19.8	18.75
Net Avail. For Common Margin %	19.15	18.31	18.15	19.8	18.75
Normalized Net Income Margin	13.21	14.69	13.01	15.43	14.71
Levered Free Cash Flow Margin	17.96	11.15	11.95	17.98	14.37
Unlevered Free Cash Flow Margin	18.76	11.92	12.82	18.9	15.38
Asset Turnover
Asset Turnover	0.62	0.64	0.64	0.58	0.57
Fixed Assets Turnover	5.9	5.77	5.11	3.85	3.34
Receivables Turnover (Average Receivables)	5.72	5.31	5.07	4.98	4.94
Inventory Turnover (Average Inventory)	3.76	3.35	3.26	2.97	3.31
Short Term Liquidity
Current Ratio	2.22	2.03	2.61	2.09	1.96
Quick Ratio	1.65	1.37	1.86	1.48	1.44
Operating Cash Flow to Current Liabilities	0.87	0.7	1.11	0.92	0.66
Days Sales Outstanding (Average Receivables)	63.83	68.68	72.01	73.51	73.84
Days Outstanding Inventory (Average Inventory)	97.14	109.06	112.11	123.21	110.27
Average Days Payable Outstanding	48.31	56.16	54.19	60.12	60.33
Cash Conversion Cycle (Average Days)	112.66	121.57	129.93	136.6	123.78
Long Term Solvency
Total Debt/Equity	54.02	55.08	49.6	60.6	52.56
Total Debt / Total Capital	35.07	35.52	33.15	37.73	34.45
LT Debt/Equity	53.05	53.42	48.81	59.12	47.4
Long-Term Debt / Total Capital	34.45	34.45	32.63	36.81	31.07
Total Liabilities / Total Assets	49.66	49.63	45.69	50.21	47.03
EBIT / Interest Expense	17.33	19.96	14.8	16.74	14.89
EBITDA / Interest Expense	22.06	24.48	18.39	20	17.92
(EBITDA - Capex) / Interest Expense	19.74	21.01	15.25	16.06	14.29
Total Debt / EBITDA	1.63	1.42	1.66	1.86	1.77
Net Debt / EBITDA	0.75	0.91	0.75	1.17	0.87
Total Debt / (EBITDA - Capex)	1.82	1.66	2	2.32	2.21
Net Debt / (EBITDA - Capex)	0.84	1.06	0.9	1.46	1.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.36	8.37	-0.22	-4.73	6.73
Gross Profit, 1 Yr. Growth %	20.09	9.25	-6.9	2.02	3.06
EBITDA, 1 Yr. Growth %	27.49	15.59	-15.9	8.31	5.05
EBITA, 1 Yr. Growth %	29.89	16.89	-17.28	7.67	3.68
EBIT, 1 Yr. Growth %	34.35	19.44	-16.16	10.83	3.93
Earnings From Cont. Operations, 1 Yr. Growth %	68.29	3.64	-1.12	3.95	1.09
Net Income, 1 Yr. Growth %	68.29	3.64	-1.12	3.95	1.09
Normalized Net Income, 1 Yr. Growth %	35.63	20.51	-11.68	12.93	1.05
Diluted EPS Before Extra, 1 Yr. Growth %	71.3	6.09	0.24	5.73	3.16
Accounts Receivable, 1 Yr. Growth %	12.91	19.88	-8.11	2.56	12.31
Inventory, 1 Yr. Growth %	15.28	25.06	-0.67	-5.72	5.45
Net Property, Plant and Equip., 1 Yr. Growth %	10.1	11.31	13.92	37.29	12.84
Total Assets, 1 Yr. Growth %	11.2	-1.62	2.19	10.06	7.44
Tangible Book Value, 1 Yr. Growth %	-1.59	22.86	165.04	-38.01	108.58
Common Equity, 1 Yr. Growth %	10.59	-1.56	10.18	0.91	14.29
Cash From Operations, 1 Yr. Growth %	61.24	-11.65	35.06	-1.19	-10.97
Capital Expenditures, 1 Yr. Growth %	57.98	54.79	2.41	26.85	7.67
Levered Free Cash Flow, 1 Yr. Growth %	93.21	-32.77	6.77	38.69	-14.59
Unlevered Free Cash Flow, 1 Yr. Growth %	86.36	-31.22	7.17	36.22	-13.07
Dividend Per Share, 1 Yr. Growth %	7.78	8.25	7.14	4.89	5.08
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	10.63	13.25	3.99	-2.5	0.84
Gross Profit, 2 Yr. CAGR %	10.21	14.54	0.85	-2.54	2.54
EBITDA, 2 Yr. CAGR %	16.04	21.4	-1.4	-3.31	6.73
EBITA, 2 Yr. CAGR %	16.85	23.22	-1.67	-4.29	5.73
EBIT, 2 Yr. CAGR %	16.02	26.68	0.07	-2.11	7.4
Earnings From Cont. Operations, 2 Yr. CAGR %	6.29	32.06	1.23	1.39	2.51
Net Income, 2 Yr. CAGR %	6.29	32.06	1.23	1.39	2.51
Normalized Net Income, 2 Yr. CAGR %	14.67	27.85	3.17	-0.09	7.19
Diluted EPS Before Extra, 2 Yr. CAGR %	8.13	34.81	3.12	2.95	4.44
Accounts Receivable, 2 Yr. CAGR %	12.26	16.34	4.95	-2.93	7.32
Inventory, 2 Yr. CAGR %	10.56	20.07	11.45	-3.23	-0.29
Net Property, Plant and Equip., 2 Yr. CAGR %	14.94	10.7	12.61	25.06	24.47
Total Assets, 2 Yr. CAGR %	6.42	4.59	0.27	6.05	8.74
Tangible Book Value, 2 Yr. CAGR %	200.35	9.96	80.45	28.17	13.71
Common Equity, 2 Yr. CAGR %	6.54	4.34	4.14	5.44	7.39
Cash From Operations, 2 Yr. CAGR %	20.6	19.35	9.24	15.52	-6.2
Capital Expenditures, 2 Yr. CAGR %	10.13	56.38	25.9	13.97	16.87
Levered Free Cash Flow, 2 Yr. CAGR %	15.78	14.02	-15.22	23.72	8.94
Unlevered Free Cash Flow, 2 Yr. CAGR %	15.23	13.27	-14.09	22.71	8.91
Dividend Per Share, 2 Yr. CAGR %	8.76	8.01	7.69	6.01	4.99
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.74	9.87	8.57	1	0.48
Gross Profit, 3 Yr. CAGR %	8.33	9.89	6.89	1.24	-0.71
EBITDA, 3 Yr. CAGR %	13.46	15.89	7.42	2.62	-0.64
EBITA, 3 Yr. CAGR %	13.94	16.86	7.89	2.3	-1.74
EBIT, 3 Yr. CAGR %	13.08	17.15	10.4	4.6	-0.18
Earnings From Cont. Operations, 3 Yr. CAGR %	56.45	5.4	19.92	2.13	1.29
Net Income, 3 Yr. CAGR %	56.45	5.4	19.92	2.13	1.29
Normalized Net Income, 3 Yr. CAGR %	11.69	16.59	13.02	6.35	0.51
Diluted EPS Before Extra, 3 Yr. CAGR %	59.55	7.44	22.13	3.98	3.02
Accounts Receivable, 3 Yr. CAGR %	14.73	14.74	7.54	4.15	1.91
Inventory, 3 Yr. CAGR %	9.17	15.2	12.71	5.41	-0.42
Net Property, Plant and Equip., 3 Yr. CAGR %	10.96	13.72	11.76	20.3	20.85
Total Assets, 3 Yr. CAGR %	7.82	3.67	3.79	3.43	6.51
Tangible Book Value, 3 Yr. CAGR %	-26.78	122.96	47.43	26.38	50.76
Common Equity, 3 Yr. CAGR %	5.67	3.77	6.25	3.05	8.31
Cash From Operations, 3 Yr. CAGR %	10.96	8.72	24.38	5.65	5.92
Capital Expenditures, 3 Yr. CAGR %	2.03	23.36	35.8	26.22	11.83
Levered Free Cash Flow, 3 Yr. CAGR %	19.09	-3.38	11.6	1	9.3
Unlevered Free Cash Flow, 3 Yr. CAGR %	18.15	-2.95	11.24	1.22	9.35
Dividend Per Share, 3 Yr. CAGR %	9.2	8.59	7.72	6.75	5.7
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.5	8.9	6.82	4.75	5.41
Gross Profit, 5 Yr. CAGR %	9.17	9.18	5.27	4.73	5.13
EBITDA, 5 Yr. CAGR %	12.81	13.36	7.26	7.79	7.65
EBITA, 5 Yr. CAGR %	13.42	13.95	7.42	7.89	7.57
EBIT, 5 Yr. CAGR %	15	14.48	7.68	9.03	9.8
Earnings From Cont. Operations, 5 Yr. CAGR %	21.24	12.89	31.45	3.78	12.63
Net Income, 5 Yr. CAGR %	21.24	12.89	31.45	3.78	12.63
Normalized Net Income, 5 Yr. CAGR %	15.68	14.59	8.2	9.6	10.67
Diluted EPS Before Extra, 5 Yr. CAGR %	22.99	14.76	34	5.62	14.72
Accounts Receivable, 5 Yr. CAGR %	13.18	14.18	10.72	7.32	7.45
Inventory, 5 Yr. CAGR %	9.26	12.54	10.07	7.44	7.32
Net Property, Plant and Equip., 5 Yr. CAGR %	11.94	10.55	11.62	18.13	16.68
Total Assets, 5 Yr. CAGR %	6.55	4.56	4.73	4.62	5.74
Tangible Book Value, 5 Yr. CAGR %	-19.86	-22.17	5.03	78.67	32.88
Common Equity, 5 Yr. CAGR %	4.9	1.89	5.06	4.43	6.71
Cash From Operations, 5 Yr. CAGR %	13.37	8.1	10.27	11.39	11.1
Capital Expenditures, 5 Yr. CAGR %	6.23	10.58	10.98	19.52	27.88
Levered Free Cash Flow, 5 Yr. CAGR %	5.6	7.03	3.97	6.69	11.2
Unlevered Free Cash Flow, 5 Yr. CAGR %	5.45	6.59	4.03	6.62	10.93
Dividend Per Share, 5 Yr. CAGR %	11.02	9.73	8.59	7.55	6.62